Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
JCO Oncology Practice
|
February 10, 2023
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
Lee Mozessohn, Qing Li, Ning Liu, et al.
American Journal of Clinical Pathology
|
October 1, 2021
Corrigendum to: Global Cytopathology-Hematopathology Practice Trends
Sara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
American Journal of Clinical Pathology
|
September 11, 2021
Global Cytopathology-Hematopathology Practice Trends
Sara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
Archives of Pathology & Laboratory Medicine
|
November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists
Steven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Annals of Hematology
|
February 22, 2022
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes
Eugene Brailovski, Qing Li, Ning Liu, et al.
American Journal of Clinical Pathology
|
November 21, 2020
Laboratory Workup of Lymphoma in Adults
Steven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Blood Advances
|
May 13, 2020
A user guide to the American Society of Hematology clinical practice guidelines
Ariel Izcovich, Adam Cuker, Robert Kunkle, et al.
European Journal of Haematology
|
May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
Bethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
Journal of the National Cancer Institute
|
April 15, 2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12
Matthew C Cheung, Annette E Hay, Michael Crump, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
JCO Oncology Practice
|
February 10, 2023
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
Lee Mozessohn, Qing Li, Ning Liu, et al.
American Journal of Clinical Pathology
|
October 1, 2021
Corrigendum to: Global Cytopathology-Hematopathology Practice Trends
Sara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
American Journal of Clinical Pathology
|
September 11, 2021
Global Cytopathology-Hematopathology Practice Trends
Sara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
Archives of Pathology & Laboratory Medicine
|
November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists
Steven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Annals of Hematology
|
February 22, 2022
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes
Eugene Brailovski, Qing Li, Ning Liu, et al.
American Journal of Clinical Pathology
|
November 21, 2020
Laboratory Workup of Lymphoma in Adults
Steven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Blood Advances
|
May 13, 2020
A user guide to the American Society of Hematology clinical practice guidelines
Ariel Izcovich, Adam Cuker, Robert Kunkle, et al.
European Journal of Haematology
|
May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
Bethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
Journal of the National Cancer Institute
|
April 15, 2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12
Matthew C Cheung, Annette E Hay, Michael Crump, et al.
Page
of 15